News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Women Can Have Confidence In Diane-35 - Schering

Schering NZ Ltd says New Zealand women can have confidence in Diane-35 and should continue to take their acne medication as usual, following their doctor's advice.

Diane-35 treats pronounced acne, hirsuitism (excessive hair growth) and polycystic ovary syndrome. Because it contains both an oestrogen (ethinylestradiol) and an anti-androgen (cyproterone acetate), women using Diane-35 do not need to take additional birth control.

The Ministry of Health today issued a statement advising women using the cyproterone acetate-containing oral contraceptive to talk to their doctor about the relative risks of oral contraceptives.

Schering supports the Ministry's view that it is important that women fully understand the benefits and risks associated with all forms of contraception, however the company considers that the recently published study the Ministry's statement is based on, has major weaknesses.

"Diane-35 is a well proven, safe and effective treatment for acne in women. Since its launch in 1985 about half a billion packs have been used by more than 35 million women worldwide. Unlike its generic competitor, Diane-35 is the only oestrogen/cyproterone acetate product on the market in New Zealand with a safety and efficacy record proven in clinical trials and in over 20 years of use," says Schering regulatory manager, Raewyn McNee.

"Diane-35 is available only on prescription and this ensures that each individual woman is assessed and advised appropriately by their doctor. The doctor will consider all risk factors before offering the best choice of therapy." Schering says women trust Diane-35 and value its therapeutic effects. Despite recent changes in funding, Diane-35 will remain available in New Zealand as many women prefer to stay on a medication on which they are well settled and which is producing results.

Detailed information for women using Diane-35 is available on Medsafe's website,

Schering AG is a research-based pharmaceutical company that has a major focus on researching and developing products for fertility control.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Reuben Moss' Property is Theft! & Kaitani at The Physics Room

Property is Theft! continues Moss’ interest in the contemporary urban environment as a space controlled by pulsing and unequal flows of capital and labour. Kaitani features work by the University of Canterbury Fijian Students Association and Kulimoe’anga Stone Maka. More>>

Handcrafted Form: Rare Treasures From Japan

This unique exhibition at Expressions Whirinaki represents 90 everyday objects made by contemporary Japanese artisans who employ various traditional craft techniques made in regional workshops. The works used in daily life are crafted from raw materials with techniques appropriate to bringing out the best of its medium, balancing ease of use with aesthetic appeal. More>>

Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>

Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>




  • Wellington
  • Christchurch
  • Auckland